Frequently Asked Questions
- Who is Competitive Technologies?
- What does CTT do?
- How does CTT operate?
- What is "technology commercialization"?
- Who develops the technology?
- What is the purpose of technology commercialization?
- What resources does CTT have to offer?
- What do you mean by CTT's global network?
- What type of technologies does CTT help commercialize?
- Who are some of CTT's customers?
- Who are some of CTT's University clients?
Competitive Technologies, Inc. (NYSE Amex: CTT) is a publicly traded company listed on the American Stock Exchange. Established in 1968, CTT focuses on the technology needs of its customers and transforming those needs into commercially viable solutions provided by its clients.
CTT is a global leader in identifying, developing and commercializing innovative technologies in life, electronic, nano and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders.
CTT develops relationships worldwide with companies who have technology requirements, their wish lists, and leverages its inventory of exclusive technologies and its extensive technology-sourcing network to identify and commercialize technologies that fulfill its customer's unsatisfied technology needs. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders by providing technology transfer and licensing services to intellectual property owners seeking to commercialize their innovations. CTT's strong global network of relationships and customized licensing programs maximizes commercialization of clients' technologies and decreases time-to-market. CTT and its clients share the license and/or royalty fees paid by CTT customers for technologies.
Technology commercialization is the process of transforming innovative technologies developed by universities, companies and inventors into commercially viable products and services that are in market demand.
CTT's strong global technology-sourcing network of intellectual property owners includes world-class universities, corporations, and federal and private research centers as well as scientists, inventors and entrepreneurs that develop the technologies to meet real market needs.
Technology commercialization brings innovative new technology solutions to the market to fulfill the needs and demands of the consumer. CTT identifies their customer's needs and actively seeks the technology solution that provides the answer to that need.
CTT has a world-class team of professionals with diverse technical, legal, intellectual property, marketing and business experience enabling it to offer a complete spectrum of solutions for the commercial optimization of technology.
CTT has built relationships and strategic alliances with both clients and customers in the US, Canada, Asia, Europe and Latin America.
CTT has successfully licensed more than 500 technologies to over 400 individual organizations. The technologies cover a broad spectrum of disciplines and industries in life, electronic, nano and physical sciences.
CTT has licensing arrangements with corporations like Siemens Medical (formerly Bayer HealthCare Diagnostics Division), Soteira, Inc. and Matsushita Electric Industrial Co., Ltd.
CTT clients include the University of Pennsylvania, the University of Colorado, the University of Illinois, the University of Arizona, the University of South Carolina, Columbia University and Lehigh University.
